Cart
sales@molnova.com
BYK191023
CAS No. 608880-48-4
BYK191023( BYK-191023 )
Catalog No. M15287 CAS No. 608880-48-4
BYK191023 (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBYK191023
-
NoteResearch use only, not for human use.
-
Brief DescriptionBYK191023 (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM.
-
DescriptionBYK191023 (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM, >20-fold selectivity over nNOS and eNOS (IC50=17 and 162 uM); exhibits an affinity for iNOS, nNOS, and eNOS of 450 nM, 30 uM, and >500 uM, respectively; inhibits cellular nitrate/nitrite synthesis in RAW, rat mesangium, and human embryonic kidney 293 cells with IC50 values 40- to 100-fold higher than at the isolated enzyme; dose-dependently suppresses the LPS-induced increase in plasma nitrate/nitrite (NO(x)) levels with ED50 of 14.9 micromol/kg/h, partially restores normal blood pressure responses to norepinephrine and sodium nitroprusside in model of LPS-induced vascular hyporesponsiveness.
-
In Vitro——
-
In Vivo——
-
SynonymsBYK-191023
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorNOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number608880-48-4
-
Formula Weight254.293
-
Molecular FormulaC14H14N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(=NC=C1)CCC2=NC3=C(N2)C=CC=N3
-
Chemical Name2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Strub A, et al. Mol Pharmacol. 2006 Jan;69(1):328-37.
2. Lehner MD, et al. J Pharmacol Exp Ther. 2006 Apr;317(1):181-7.
3. Tiso M, et al. Mol Pharmacol. 2008 Apr;73(4):1244-53.
4. Higashi Y, et al. Br J Pharmacol. 2018 Jul 14. doi: 10.1111/bph.14445.
molnova catalog
related products
-
iNOS-IN-14
iNOS-IN-14 (3-bromo-1H-indazole-7-carbonitrile) is a potent nitric oxide synthase (NOS) inhibitor that inhibits the NADPH oxidase activity of nNOS.
-
Resveratroloside
Resveratroloside has cardioprotective effect, it exhibits α±-glucosidase inhibitory activity, it also can inhibit hydroxylation of testosterone by CYP3A4.
-
ZLc002
ZLc002 (ZLc-002) is a putative small-molecule inhibitor of nNOS interaction with NOS1AP.
